The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
Abstract Backgrounds The aberrant activation of complement system is critically involved in lupus nephropathy. Recent study showed complement C3 inhibitor was effective in the treatment of lupus nephropathy. In this study, we investigate the effect of a novel complement C3 inhibitor, CRIg/FH, in the...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2019-11-01
|
| Serija: | BMC Nephrology |
| Teme: | |
| Online pristup: | http://link.springer.com/article/10.1186/s12882-019-1599-0 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|